BACKGROUND: Genetic variation influences susceptibility or resistance to tuberculosis. Interleukin 6 (IL-6) contributes to protection against tuberculosis in mice. However, its role in regulating susceptibility or resistance to tuberculosis in humans is unclear. METHODS: Genotyping of polymorphisms in IL-6 and IL-6R (CD126) genes was performed in 2 independent cohorts, an experimental population (495 cases and 358 controls) and a validation population (1383 cases and 1149 controls). The associations of the variants with tuberculosis were tested using 2 case-control association studies. In addition, the regulatory effects of single-nucleotide polymorphism rs1800796 (-572C > G) on IL-6 production in plasma and CD14(+) monocyte cultures stimulated with a Mycobacterium tuberculosis (M. tuberculosis) product were assessed. RESULTS: The rs1800796 polymorphism is associated with increased resistance to tuberculosis (odds ratio [OR], 0.771; 95% confidential interval, .684-.870). The rs1800796GG genotype is strongly associated with reduced risk to tuberculosis (OR, 0.621; 95% CI, .460-.838). Interestingly, CD14(+) monocytes isolated from individuals with rs1800796GG genotype produced significantly less IL-6 in response to M. tuberculosis 19-kDa lipoprotein than those with CC or CG genotype. CONCLUSIONS: We identified a genetic polymorphism in the IL-6 promoter that regulates cytokine production and host resistance to pulmonary tuberculosis in Chinese populations.
BACKGROUND: Genetic variation influences susceptibility or resistance to tuberculosis. Interleukin 6 (IL-6) contributes to protection against tuberculosis in mice. However, its role in regulating susceptibility or resistance to tuberculosis in humans is unclear. METHODS: Genotyping of polymorphisms in IL-6 and IL-6R (CD126) genes was performed in 2 independent cohorts, an experimental population (495 cases and 358 controls) and a validation population (1383 cases and 1149 controls). The associations of the variants with tuberculosis were tested using 2 case-control association studies. In addition, the regulatory effects of single-nucleotide polymorphism rs1800796 (-572C > G) on IL-6 production in plasma and CD14(+) monocyte cultures stimulated with a Mycobacterium tuberculosis (M. tuberculosis) product were assessed. RESULTS: The rs1800796 polymorphism is associated with increased resistance to tuberculosis (odds ratio [OR], 0.771; 95% confidential interval, .684-.870). The rs1800796GG genotype is strongly associated with reduced risk to tuberculosis (OR, 0.621; 95% CI, .460-.838). Interestingly, CD14(+) monocytes isolated from individuals with rs1800796GG genotype produced significantly less IL-6 in response to M. tuberculosis 19-kDa lipoprotein than those with CC or CG genotype. CONCLUSIONS: We identified a genetic polymorphism in the IL-6 promoter that regulates cytokine production and host resistance to pulmonary tuberculosis in Chinese populations.
Authors: Vijaya Nagabhushanam; Alejandra Solache; Li-Min Ting; Claire J Escaron; Jennifer Y Zhang; Joel D Ernst Journal: J Immunol Date: 2003-11-01 Impact factor: 5.422
Authors: Mulin Jun Li; Panwen Wang; Xiaorong Liu; Ee Lyn Lim; Zhangyong Wang; Meredith Yeager; Maria P Wong; Pak Chung Sham; Stephen J Chanock; Junwen Wang Journal: Nucleic Acids Res Date: 2011-12-01 Impact factor: 16.971
Authors: Murilo Delgobo; Daniel Agb Mendes; Edgar Kozlova; Edroaldo Lummertz Rocha; Gabriela F Rodrigues-Luiz; Lucas Mascarin; Greicy Dias; Daniel O Patrício; Tim Dierckx; Maíra A Bicca; Gaëlle Bretton; Yonne Karoline Tenório de Menezes; Márick R Starick; Darcita Rovaris; Joanita Del Moral; Daniel S Mansur; Johan Van Weyenbergh; André Báfica Journal: Elife Date: 2019-10-22 Impact factor: 8.140
Authors: G Zhang; W Wang; S Li; H Yang; M Zhang; P Zhang; Y Wen; A Wu; L Yang; B Zhou; X Chen Journal: Genes Immun Date: 2015-10-08 Impact factor: 2.676